Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02385357
Other study ID # Puleva
Secondary ID
Status Recruiting
Phase Phase 0
First received February 10, 2015
Last updated March 10, 2015
Start date February 2015
Est. completion date December 2015

Study information

Verified date March 2015
Source Puleva Biotech
Contact Federico Lara, PhD
Phone 0034958240100
Email Federico.LaraVilloslada@puleva.es
Is FDA regulated No
Health authority Spain: Ethics Committee
Study type Interventional

Clinical Trial Summary

There is no conclusive evidence about the effect of intake of protein-enriched drink after and acute high intensity exercise bout on muscle function and damage. The investigators aimed to study the effect of a protein-enriched drink on muscle function recovery following an acute high intensity exercise bout. The present counterbalanced, crossover, and double blind study will involve a total of 12 active men.


Description:

Participants will run downhill (-10%) during 30 min at a intensity equivalent to 75-80% of their maximum heart rate (previously determined). After the exercise bout, participants will have either the placebo or the experimental drink. The investigators will measure muscle function and damage-related parameters right after the exercise as well as the three following days. This protocol will be repeated after a wash out period of 3 weeks, where the participants will have the other drink. The investigators will control exercise and diet three weeks before study entry, during the experimental week as the investigators as during the wash out period.


Recruitment information / eligibility

Status Recruiting
Enrollment 12
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Recreational triathletes with 2 years of experience

- Maximum oxygen uptake : =55 ml/kg/min

- Fat mass: 8-20% measured by dual energy x-ray absorptiometry

- Not participating in another study

- Not having ergogenic aids

- Not participating in a weight loss program

- Normal electrocardiogram

- Participants must be capable and willing to provide consent, understand exclusion criteria and accept the randomized group assignment

Exclusion Criteria:

- History of cardiovascular disease

- Diabetes or hypertension

- Medication for hypertension, hyperlipidemia, hyperuricemia or other illness.

- Smoking

- Other significant medical conditions that are life-threatening or that can interfere with or be aggravated by exercise.

- Unwillingness to either complete the study requirements or to be randomized into control or training group.

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Protein-enriched drink
Participants will drink 330 ml of a protein-enriched drink (6 g/ml of protein) after a high intensity exercise that induce muscle damage (30 min running downhill with a slope of -10º)

Locations

Country Name City State
Spain Biosearch Life Granada

Sponsors (2)

Lead Sponsor Collaborator
Puleva Biotech Universidad de Granada

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Isometric muscle strength Isometric muscle strength of lower limbs at 90% angle. Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink No
Secondary Muscle soreness of lower limbs self-reported by a visual anagogic scale and with an algometer score. Muscle soreness of the lower limbs will be self-reported by a visual anagogic scale and with an algometer score. Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink Yes
Secondary Power output assessed with the 30sec. Wingate anaerobic test Power output will be assessed with the 30sec. Wingate anaerobic test. Change from post- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink No
Secondary Creatine kinase Creatine kinase will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink No
Secondary Urine Creatinine Concentration of creatinine in urine will be assessed after the protein-enriched drink to assess muscle recovery after a high intensity exercise bout Change from post- protein-enriched drink to 24, 48 hrs post- protein-enriched drink No
Secondary Resting metabolic rate Change from pre- protein-enriched drink to 24, 48 and 72 hrs post- protein-enriched drink No
Secondary Time limit (time that the participant is able to run 90% of his determined maximum aerobic velocity) We will measure the time that the participant is able to run 90% of his determined maximum aerobic velocity 24hrs after protein-enriched drink No
See also
  Status Clinical Trial Phase
Recruiting NCT06042907 - Development, Validation, and Evaluation of a Risk Assessment Tool for Contractures: the ORACLE Study
Not yet recruiting NCT06377085 - Repurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy Phase 1
Recruiting NCT06308380 - Effectiveness of Rehabilitation Protocol in Patients With Shortened Posterior Leg Muscles N/A
Completed NCT01639651 - The Acute Effect of a Mobilization With Movement Technique to Improve Internal Rotation of the Shoulder Phase 0
Completed NCT01777386 - Perforator Artery Changes During Suprafascial Pre-expansion of the Perforator Flaps N/A
Recruiting NCT06051656 - Effect of Cryoneurolysis on Pain in Patients With Hand Contracture.
Completed NCT03008486 - Long Term Effects of Soft Splints on Stroke Patients and Patients With Disorders of Consciousness Phase 2
Completed NCT01882556 - Early Use of Botulinum Toxin in Spasticity Post Stroke. Phase 2
Recruiting NCT05440240 - Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture Phase 4
Recruiting NCT03475654 - A Prospective Trial of Virtual Home Rehabilitation After Burn Injury N/A
Completed NCT02975531 - Simulator of Pompage Technique for Physiotherapists N/A
Completed NCT02861521 - Reducing Recurrent Knee Flexion Contracture by Correcting Leg Length Discrepancy After Total Knee Arthroplasty for OA N/A